Improving Immunotherapy’s Success: The Power of NK Cells and SDCs
A recent study published in Nature Medicine reveals new ways to determine which cancer patients will respond best to immunotherapy with checkpoint inhibitors. This kind of therapy has shown great potential in effectively removing malignancies in about 20 to 40 percent of patients with cancers like melanoma, but there are still many patients whose cancer […]
Continue readingAdvancements in Immunotherapy Changing the Landscape of Cancer Treatment
Cancer patients have a better chance at beating diseases with the help of immunotherapy, a type of cancer treatment, as studies are now showing. Two new immunotherapy drugs have recently been approved by the Food and Drug Administration last March. One of the immunotherapies approved is Keytruda, which is made to treat Hodgkin’s lymphoma for […]
Continue reading